A major new study for families with ADHD has been published in the Journal of Clinical Psychiatry. This article examines the complex comorbidities and the unique challenges presented by our patients in clinical practice. This study enrolled not only adults with ADHD but also those experiencing concurrent anxiety, depression, insomnia, and/or cannabis use. The findings demonstrate real-world improvements in mood, anxiety, and sleep when ADHD is better managed.

Read more: https://www.psychiatrist.com/jcp/viloxazine-extended-release-adhd-depression-anxiety-open-label-phase-4-trial/

A recent study published in JAMA Psychiatry examines how the age at first attention-deficit/hyperactivity disorder (ADHD) diagnosis is associated with educational outcomes. Drawing on a large population-based cohort, the findings suggest that earlier diagnosis is linked to higher academic performance, greater likelihood of pursuing academic education, and lower risk of school dropout, while later diagnosis, particularly during adolescence, may place individuals at increased risk for poorer educational trajectories. The study highlights the importance of timely identification and the need for targeted support for those diagnosed later in development.

Read more: https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2847662